Literature DB >> 2674694

Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly differentiated and well differentiated human colon carcinoma cells.

K M Mulder1, M G Brattain.   

Abstract

We demonstrate the differential sensitivity of poorly differentiated and well differentiated human colon carcinoma cells to nutrients alone or to nutrients and polypeptide growth factors under completely serum-free conditions. 3H-Thymidine incorporation into trichloroacetic acid precipitable material and autoradiographic analysis indicated that nutrient replenishment alone was sufficient to initiate DNA synthesis in quiescent poorly differentiated cells, whereas defined polypeptide growth factors produced no additional effect. In contrast, well differentiated cells were mitogenically stimulated to a much greater extent by growth factors (epidermal growth factor + insulin + transferrin), than by nutrient replenishment alone. Expression of the c-myc protooncogene was increased approximately 5-fold after growth factor addition to the well differentiated cells. Maximal expression of c-myc occurred at 4 h post stimulation. In contrast, nutrients resulted in only a slight up-regulation of c-myc (1.8-fold) at approximately 90 min after addition. Addition of nutrients and/or growth factors to the poorly differentiated colon carcinoma cells resulted in an initial decline in c-myc expression (90 min), presumably due to removal of endogenous growth stimulators. Expression of c-myc returned to baseline levels by 24 h after additions. The results indicate that differential sensitivity to polypeptide growth factors is related to differentiation status in this model system and suggest that the insensitivity of poorly differentiated cells to exogenous growth factors may be due to a greater production of autocrine growth stimulators.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2674694     DOI: 10.1210/mend-3-8-1215

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  11 in total

1.  Measurement of DNA mismatch repair activity in live cells.

Authors:  Xiufen Lei; Yong Zhu; Alan Tomkinson; LuZhe Sun
Journal:  Nucleic Acids Res       Date:  2004-07-12       Impact factor: 16.971

2.  Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor.

Authors:  Yi Peter Hu; Sandip B Patil; Michelle Panasiewicz; Wenhui Li; Jennie Hauser; Lisa E Humphrey; Michael G Brattain
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

3.  Regulation of transforming growth factor alpha expression in a growth factor-independent cell line.

Authors:  G M Howell; L E Humphrey; B L Ziober; R Awwad; B Periyasamy; A Koterba; W Li; J K Willson; K Coleman; J Carboni; M Lynch; M G Brattain
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

4.  Inhibition of skeletal metastasis by ectopic ERalpha expression in ERalpha-negative human breast cancer cell lines.

Authors:  Abhik Bandyopadhyay; Long Wang; Shiau Hui Chin; Lu-Zhe Sun
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

5.  The role of growth regulatory aberrations in progression of human colon carcinoma.

Authors:  G M Howell; L Sun; B L Ziober; S P Wu; M G Brattain
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

6.  Isolation and characterization of a metastatic hybrid cell line generated by ER negative and ER positive breast cancer cells in mouse bone marrow.

Authors:  Keya De Mukhopadhyay; Abhik Bandyopadhyay; Ting-Tung A Chang; Abdel G Elkahloun; John E Cornell; Junhua Yang; Beth A Goins; I-Tien Yeh; Lu-Zhe Sun
Journal:  PLoS One       Date:  2011-06-01       Impact factor: 3.240

7.  Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells.

Authors:  Kristin M Müller; Ingun H Tveteraas; Monica Aasrum; John Ødegård; Mona Dawood; Olav Dajani; Thoralf Christoffersen; Dagny L Sandnes
Journal:  BMC Cancer       Date:  2011-10-02       Impact factor: 4.430

8.  Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions.

Authors:  L O Murphy; M W Cluck; S Lovas; F Otvös; R F Murphy; A V Schally; J Permert; J Larsson; J A Knezetic; T E Adrian
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

9.  TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector.

Authors:  S P Wu; D Theodorescu; R S Kerbel; J K Willson; K M Mulder; L E Humphrey; M G Brattain
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

10.  Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer.

Authors:  Ekta Agarwal; Anathbandhu Chaudhuri; Premila D Leiphrakpam; Katie L Haferbier; Michael G Brattain; Sanjib Chowdhury
Journal:  BMC Cancer       Date:  2014-03-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.